相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative psychometric properties of the BACS and RBANS in patients with schizophrenia and schizoaffective disorder
Jean-Marc Chianetta et al.
SCHIZOPHRENIA RESEARCH (2008)
Validation of the French version of the BACS (the brief assessment of cognition in schizophrenia) among 50 French schizophrenic patients
Marie-Cecile Bralet et al.
EUROPEAN PSYCHIATRY (2007)
Factors associated with antipsychotic dosing in psychiatric inpatients:: a prospective study
Corrado Barbui et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2007)
A case-control study of patients with resistant schizophrenia after clozapine discontinuation
Julie Marchand et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Does antipsychotic polypharmacy increase the risk for metabolic syndrome?
Christoph U. Correll et al.
SCHIZOPHRENIA RESEARCH (2007)
Antipsychotic medication and cognitive function in schizophrenia
Hiroaki Hori et al.
SCHIZOPHRENIA RESEARCH (2006)
High-dose of multiple antipsychotics and cognitive function in schizophrenia: The effect of dose-reduction
Nobutoshi Kawai et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review
Allen E. Thornton et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Clozapine alone versus clozapine and risperidone with refractory schizophrenia
WG Honer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The relationship of the brief assessment of cognition in schizophrenia (BACS) to functional capacity and real-world functional outcome
RSE Keefe et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2006)
Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia
F Mouaffak et al.
CLINICAL NEUROPHARMACOLOGY (2006)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Trends in the pharmacological treatment of patients with schizophrenia over a 12 year observation period
M Edlinger et al.
SCHIZOPHRENIA RESEARCH (2005)
Polypharmacy and excessive dosing: Psychiatrists' perceptions of antipsychotic drug prescription
H Ito et al.
BRITISH JOURNAL OF PSYCHIATRY (2005)
Dosing of second-generation antipsychotic medication in a state hospital system
L Citrome et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
Treatment response to olanzapine and haloperidol and its association with dopamine D2 receptor occupancy in first-episode psychosis
RB Zipursky et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2005)
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Douglas Faries et al.
BMC PSYCHIATRY (2005)
Clozapine augmented with risperidone in the treatment of schizophrenia: A randomized, double-blind, placebo-controlled trial
RC Josiassen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Dose response and dose equivalence of antipsychotics
JM Davis et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Multiple versus single antipsychotic agents for hospitalized psychiatric patients: Case-control study of risks versus benefits
F Centorrino et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Age at onset and cognitive functioning in schizophrenia
A Tuulio-Henriksson et al.
BRITISH JOURNAL OF PSYCHIATRY (2004)
High dose antipsychotic use in schizophrenia: Findings of the REAP (Research on East Asia Psychotropic Prescriptions) study
K Sim et al.
PHARMACOPSYCHIATRY (2004)
The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery
RSE Keefe et al.
SCHIZOPHRENIA RESEARCH (2004)
A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: Opening a closed book
AL Mishara et al.
BIOLOGICAL PSYCHIATRY (2004)
The Schizophrenia Patient Outcomes Research Team (PORT): Updated treatment recommendations 2003
AF Lehman et al.
SCHIZOPHRENIA BULLETIN (2004)
Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine
J Munro et al.
ACTA PSYCHIATRICA SCANDINAVICA (2004)
Exploring cognitive complaints in schizophrenia: The subjective scale to investigate cognition in schizophrenia
E Stip et al.
COMPREHENSIVE PSYCHIATRY (2003)
Chlorpromazine equivalent doses for the newer atypical antipsychotics
SW Woods
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Inpatient antipsychotic drug use in 1998, 1993, and 1989
F Centorrino et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Relationship between neuroleptic dosage and subjective cognitive dysfunction in schizophrenic patients treated with either conventional or atypical neuroleptic medication
S Moritz et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2002)
Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment
PD Harvey et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
The National Adult Reading Test as a measure of premorbid IQ in schizophrenia
AJ Russell et al.
BRITISH JOURNAL OF CLINICAL PSYCHOLOGY (2000)
Predicting haloperidol occupancy of central dopamine D-2 receptors from plasma levels
PB Fitzgerald et al.
PSYCHOPHARMACOLOGY (2000)
分享论文
